Meropenem NDC 0409-0222

Product information

Brand name (proprietary)

Meropenem

Generic name (nonproprietary)

meropenem

Active ingredients

Meropenem — 500 mg/10mL

Dosage form

Injection, Powder, For solution

Route

Intravenous

Labeler

Hospira, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 091404

Marketing start

Dec 6, 2022

Listing expires

Dec 31, 2026

Other FDA classes

Carbapenems (Chemical structure)

Identifiers

Product ID 0409-0222_2ad24c61-4908-4053-997a-9d0a9e6810dcSPL ID 2ad24c61-4908-4053-997a-9d0a9e6810dcSPL set ID e9b6555f-20a1-4415-bb80-3d034cfab95bRxCUI 1722934, 1722939UNII FV9J3JU8B1

Pharmacologic class

Penem Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409022210 followed by a unit qualifier and the quantity Copy

Package 00409-0222-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 091404

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.